To examine if TNF-α could increase the in vivo NF-κB binding to the HAS3 promoter in oral cancer cells, we performed ChIP-qPCR analysis of NF-κB sites I and II in P1, III in P2 and IV in P3 promoter regions. Here, HAS3 is linked to lip and oral cavity carcinoma.